Status:

COMPLETED

Exercise and Quality of Life in Leukemia Patients

Lead Sponsor:

UNC Lineberger Comprehensive Cancer Center

Conditions:

Acute Leukemia

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the impact of an exercise intervention on patient-reported anxiety, depression, fatigue, and sleep disturbances among acute leukemia patients. The investigator...

Detailed Description

The purpose of this randomized, prospective, longitudinal study is to evaluate the impact of an exercise intervention on patient-reported anxiety, depression, fatigue, and sleep disturbances outcomes ...

Eligibility Criteria

Inclusion

  • Newly diagnosed with acute leukemia by pathology report
  • Admitted for induction chemotherapy within in the previous 96 hours or +/- 3 days from initiation of induction chemotherapy
  • An expected hospital stay of 3-4 weeks or longer
  • Participation in the study must be approved by the physician directly responsible for the patient's care while at University of North Carolina -Hospitals
  • Age \>21 years of age
  • Willing and able to provide, signed informed consent
  • Willing and able to use a computer to complete study questionnaires
  • Ability to understand and speak English

Exclusion

  • The criteria below will be determined by the patient's physician and a review of the patient's medical history. If any of the exclusion criteria are observed, the patients will be informed and excluded from participating in the study.
  • Participation in this study will involve the same risks as any exercise regimen. Given the potential risks involved, patients will be screened for exclusion based upon the following criteria:
  • Cardiovascular disease (unless the disease would not compromise the patient's ability to participate in the exercise rehabilitation program)
  • Acute or chronic respiratory disease that would compromise the patient's ability to participate in the exercise rehabilitation program
  • Acute or chronic bone, joint, or muscular abnormalities that would compromise the patient's ability to participate in the exercise rehabilitation program
  • Inability to understand and speak English
  • Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent
  • Another active malignancy
  • Patients will also be excluded if they have active bleeding, acute thrombosis, ischemia, hemodynamically unstable, and uncontrolled pain.

Key Trial Info

Start Date :

January 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2015

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT02246907

Start Date

January 1 2014

End Date

December 1 2015

Last Update

November 23 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of North Carolina Lineberger Comprehenisive Cancer Center

Chapel Hill, North Carolina, United States, 27599